Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease

Dag Nyholm, A Ingela M Nilsson Remahl, Nil Dizdar, +4

Neurology

Consensus statement from the 2014 International Microdialysis Forum

Peter J. Hutchinson, Ibrahim Jalloh, Adel Helmy, +45

Intensive Care Medicine

Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease

Lasse Pihlstrøm, Gunnar Axelsson, Kari Anne Bjørnarå, +11

Neurobiology of Aging

Genome-wide Association StudyGeneticsGenetic EpidemiologyComplex DiseaseSupportive Evidence +6

Group-based music intervention in Parkinson’s disease – findings from a mixed-methods study

Petra Pohl, Ewa Wressle, Fredrik Lundin, +2

Clinical Rehabilitation

The Ronnie Gardiner Rhythm and Music Method – a feasibility study in Parkinson’s disease

Petra Pohl, Nil Dizdar, Eva Hallert

Disability and Rehabilitation

Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study

Björn Holmberg, Werner Poewe, Gregor K. Wenning, +7

Movement Disorders

Growth HormoneCardiovascular DiseaseHuman GrowthEndocrine DiseaseMultiple System Atrophy +7

Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease

Sven Pålhagen, Nil Dizdar, Tove Hauge, +7

Acta Neurologica Scandinavica

Fine mapping and resequencing of the PARK16 locus in Parkinson’s disease

Lasse Pihlstrøm, Aina Rengmark, Kari Anne Bjørnarå, +10

Journal of Human Genetics

Neurodegenerative DiseasesParkinson DiseaseParkinson ’Degenerative DiseaseDegenerative Pathology +6

Improving self‐management for persons with Parkinson's disease through education focusing on management of daily life: Patients’ and relatives’ experience of the Swedish National Parkinson School

Carina Hellqvist, Nil Dizdar, Peter Hagell, +2

Journal of Clinical Nursing

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson’s disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs

Sven Pålhagen, Olof Sydow, Anders Johansson, +10

Parkinsonism & Related Disorders